Definitive Healthcare Corp. Stock Price, News & Analysis

Definitive Healthcare (Nasdaq: DH) has launched Passport Express, integrating analytical data from Analytical Wizards with extensive therapy-specific data. This new product enhances biopharma pre-launch planning across 20 therapy areas, providing vital commercial intelligence to accelerate market performance.

Passport Express offers ready-to-use analytics with up to seven interactive dashboards focused on market and brand dynamics, treatment pathways, and patient compliance. The aim is to simplify data sourcing for biopharma companies, ensuring up-to-date information is readily accessible.

Definitive Healthcare Corp. (Nasdaq: DH) will release its second quarter financial results for the period ending June 30, 2022, on August 4, 2022, after market close. A conference call will be held at 5:00 PM ET to discuss these results, which can be accessed via a live audio webcast on the company's Investor Relations website. A replay of the call will be available until August 18, 2022. Definitive Healthcare is known for transforming data into healthcare commercial intelligence, helping clients navigate market opportunities.

Definitive Healthcare (Nasdaq: DH) has launched Monocl ExpertInsight 2.0 and its mobile app Monocl ExpertGO, revolutionizing expert identification in healthcare. This platform grants medical affairs teams access to nearly 13 million expert profiles globally, enhancing productivity and streamlining workflows. Key features include live filters, advanced search options, and KOL mapping. Brazilian healthcare data has also been added to the platform. Existing customers can access these tools at no extra cost, aimed at accelerating drug and device market readiness.

Definitive Healthcare Corp. (Nasdaq: DH) will present at the Stifel 2022 Cross Sector Insight Conference. The session is scheduled for June 7, 2022, at 1:15 p.m. Eastern Time, featuring CEO Jason Krantz, CFO Rick Booth, and President Robert Musslewhite. Interested parties can access a live webcast on Definitive Healthcare's investor relations website, with a replay available for a limited time. Definitive Healthcare specializes in healthcare commercial intelligence, using data and analytics to help clients succeed in the healthcare market.

Definitive Healthcare Corp. (Nasdaq: DH) announced that CEO Jason Krantz and CFO Rick Booth will present at the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference. The presentation is scheduled for May 23, 2022, at 9:20 a.m. Eastern Time. A live webcast will be accessible through their investor relations website, with a replay available for a limited time. Definitive Healthcare specializes in healthcare commercial intelligence, providing clients insights to drive success in the healthcare market.

Definitive Healthcare Corp. (Nasdaq: DH) reported a 36% year-over-year increase in first-quarter revenue, reaching $50.1 million compared to $36.9 million in Q1 2021. Despite a net loss of ($13.1) million, which is 26% of revenue, the company showed strong operational cash flow at $13.6 million, or 27% of revenue. Adjusted net income rose to $7.7 million, highlighting profitability amidst growth. Looking ahead, the company forecasts Q2 2022 revenue between $53.0 - $54.0 million, indicating continued momentum.

Definitive Healthcare Corp. (Nasdaq: DH) announced the appointment of Robert Musslewhite as the new CEO, effective August 1, 2022. Founder Jason Krantz will transition to Executive Chairman but will remain involved in the company's strategic direction. Musslewhite, previously President, has a strong SaaS and healthcare background, including experience as CEO at OptumInsight and The Advisory Board Company. He aims to leverage his expertise to further advance the company's growth. Definitive Healthcare emphasizes its commitment to healthcare commercial intelligence with nearly 3,000 customers.

Definitive Healthcare Corp. (Nasdaq: DH) announced that it will release its first quarter financial results for the period ending March 31, 2022, on May 5, 2022, after market close. A conference call and webcast will be held at 4:30 PM ET to discuss these results. Interested parties can access the audio webcast on Definitive Healthcare's Investor Relations website. A replay of the call will be available until May 19, 2022, using the provided dial-in numbers.